Annabidiol Corp.
Annabidiol Corp. (ACBD) Stock Competitors & Peer Comparison
See (ACBD) competitors and their performances in Stock Market.
Peer Comparison Table: Shell Companies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ACBD | $0.10 | +0.00% | 4.1M | N/A | N/A | N/A |
| QMIS | $0.25 | +0.00% | 30.5B | N/A | N/A | N/A |
| GSHN | $22.70 | +2.71% | 9.3B | -2270.00 | -$0.01 | N/A |
| KATX | $1.05 | +0.00% | 1.9B | N/A | N/A | N/A |
| CCYC | $11.25 | +0.00% | 1.7B | N/A | N/A | N/A |
| WPCBF | $0.00 | +100.00% | 700.3M | N/A | N/A | N/A |
| NOTR | $13.00 | +0.00% | 570.9M | -433.33 | -$0.03 | N/A |
| WCHS | $5.01 | +0.00% | 531.9M | N/A | N/A | N/A |
| FZRO | $2.00 | N/A | 346.2M | -0.00 | -$4,243,300.50 | N/A |
| RGLG | $1.13 | +11.88% | 342.8M | -0.11 | -$10.00 | N/A |
Stock Comparison
ACBD vs QMIS Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, QMIS has a market cap of 30.5B. Regarding current trading prices, ACBD is priced at $0.10, while QMIS trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas QMIS's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to QMIS's ROE of N/A. Regarding short-term risk, ACBD and QMIS have similar daily volatility (0.00).Check QMIS's competition here
ACBD vs GSHN Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GSHN has a market cap of 9.3B. Regarding current trading prices, ACBD is priced at $0.10, while GSHN trades at $22.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GSHN's P/E ratio is -2270.00. In terms of profitability, ACBD's ROE is +1.19%, compared to GSHN's ROE of +0.04%. Regarding short-term risk, ACBD and GSHN have similar daily volatility (0.00).Check GSHN's competition here
ACBD vs KATX Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, KATX has a market cap of 1.9B. Regarding current trading prices, ACBD is priced at $0.10, while KATX trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas KATX's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to KATX's ROE of +2.21%. Regarding short-term risk, ACBD is less volatile compared to KATX. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check KATX's competition here
ACBD vs CCYC Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CCYC has a market cap of 1.7B. Regarding current trading prices, ACBD is priced at $0.10, while CCYC trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CCYC's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to CCYC's ROE of +1.16%. Regarding short-term risk, ACBD and CCYC have similar daily volatility (0.00).Check CCYC's competition here
ACBD vs WPCBF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, WPCBF has a market cap of 700.3M. Regarding current trading prices, ACBD is priced at $0.10, while WPCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas WPCBF's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to WPCBF's ROE of +0.00%. Regarding short-term risk, ACBD and WPCBF have similar daily volatility (0.00).Check WPCBF's competition here
ACBD vs NOTR Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, NOTR has a market cap of 570.9M. Regarding current trading prices, ACBD is priced at $0.10, while NOTR trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas NOTR's P/E ratio is -433.33. In terms of profitability, ACBD's ROE is +1.19%, compared to NOTR's ROE of +0.64%. Regarding short-term risk, ACBD is less volatile compared to NOTR. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check NOTR's competition here
ACBD vs WCHS Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, WCHS has a market cap of 531.9M. Regarding current trading prices, ACBD is priced at $0.10, while WCHS trades at $5.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas WCHS's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to WCHS's ROE of +1.70%. Regarding short-term risk, ACBD and WCHS have similar daily volatility (0.00).Check WCHS's competition here
ACBD vs FZRO Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, FZRO has a market cap of 346.2M. Regarding current trading prices, ACBD is priced at $0.10, while FZRO trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas FZRO's P/E ratio is -0.00. In terms of profitability, ACBD's ROE is +1.19%, compared to FZRO's ROE of +0.00%. Regarding short-term risk, ACBD and FZRO have similar daily volatility (0.00).Check FZRO's competition here
ACBD vs RGLG Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, RGLG has a market cap of 342.8M. Regarding current trading prices, ACBD is priced at $0.10, while RGLG trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas RGLG's P/E ratio is -0.11. In terms of profitability, ACBD's ROE is +1.19%, compared to RGLG's ROE of -1.03%. Regarding short-term risk, ACBD is less volatile compared to RGLG. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check RGLG's competition here
ACBD vs CINV Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CINV has a market cap of 338.6M. Regarding current trading prices, ACBD is priced at $0.10, while CINV trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CINV's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to CINV's ROE of +0.59%. Regarding short-term risk, ACBD and CINV have similar daily volatility (0.00).Check CINV's competition here
ACBD vs DVTC Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, DVTC has a market cap of 272.5M. Regarding current trading prices, ACBD is priced at $0.10, while DVTC trades at $5.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas DVTC's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to DVTC's ROE of N/A. Regarding short-term risk, ACBD and DVTC have similar daily volatility (0.00).Check DVTC's competition here
ACBD vs AMRR Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, AMRR has a market cap of 250.6M. Regarding current trading prices, ACBD is priced at $0.10, while AMRR trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas AMRR's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to AMRR's ROE of +0.70%. Regarding short-term risk, ACBD and AMRR have similar daily volatility (0.00).Check AMRR's competition here
ACBD vs AGGI Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, AGGI has a market cap of 179.7M. Regarding current trading prices, ACBD is priced at $0.10, while AGGI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas AGGI's P/E ratio is 4.45. In terms of profitability, ACBD's ROE is +1.19%, compared to AGGI's ROE of +1.01%. Regarding short-term risk, ACBD and AGGI have similar daily volatility (0.00).Check AGGI's competition here
ACBD vs KAST Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, KAST has a market cap of 164.6M. Regarding current trading prices, ACBD is priced at $0.10, while KAST trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas KAST's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to KAST's ROE of +0.03%. Regarding short-term risk, ACBD is less volatile compared to KAST. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check KAST's competition here
ACBD vs SCGX Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, SCGX has a market cap of 140.7M. Regarding current trading prices, ACBD is priced at $0.10, while SCGX trades at $7.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas SCGX's P/E ratio is -0.01. In terms of profitability, ACBD's ROE is +1.19%, compared to SCGX's ROE of -0.44%. Regarding short-term risk, ACBD and SCGX have similar daily volatility (0.00).Check SCGX's competition here
ACBD vs XTPT Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, XTPT has a market cap of 130.7M. Regarding current trading prices, ACBD is priced at $0.10, while XTPT trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas XTPT's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to XTPT's ROE of -8.74%. Regarding short-term risk, ACBD is less volatile compared to XTPT. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check XTPT's competition here
ACBD vs TGLO Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, TGLO has a market cap of 106M. Regarding current trading prices, ACBD is priced at $0.10, while TGLO trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas TGLO's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to TGLO's ROE of +0.18%. Regarding short-term risk, ACBD is less volatile compared to TGLO. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check TGLO's competition here
ACBD vs TRFE Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, TRFE has a market cap of 101M. Regarding current trading prices, ACBD is priced at $0.10, while TRFE trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas TRFE's P/E ratio is -1.92. In terms of profitability, ACBD's ROE is +1.19%, compared to TRFE's ROE of -0.27%. Regarding short-term risk, ACBD and TRFE have similar daily volatility (0.00).Check TRFE's competition here
ACBD vs NMTT Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, NMTT has a market cap of 90.6M. Regarding current trading prices, ACBD is priced at $0.10, while NMTT trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas NMTT's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to NMTT's ROE of N/A. Regarding short-term risk, ACBD and NMTT have similar daily volatility (0.00).Check NMTT's competition here
ACBD vs RMGCF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, RMGCF has a market cap of 89.2M. Regarding current trading prices, ACBD is priced at $0.10, while RMGCF trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas RMGCF's P/E ratio is -14.41. In terms of profitability, ACBD's ROE is +1.19%, compared to RMGCF's ROE of +0.03%. Regarding short-term risk, ACBD is less volatile compared to RMGCF. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check RMGCF's competition here
ACBD vs WAYS Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, WAYS has a market cap of 86.5M. Regarding current trading prices, ACBD is priced at $0.10, while WAYS trades at $4.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas WAYS's P/E ratio is -49.72. In terms of profitability, ACBD's ROE is +1.19%, compared to WAYS's ROE of -0.14%. Regarding short-term risk, ACBD and WAYS have similar daily volatility (0.00).Check WAYS's competition here
ACBD vs USCTF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, USCTF has a market cap of 85.9M. Regarding current trading prices, ACBD is priced at $0.10, while USCTF trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas USCTF's P/E ratio is -19.00. In terms of profitability, ACBD's ROE is +1.19%, compared to USCTF's ROE of +0.94%. Regarding short-term risk, ACBD and USCTF have similar daily volatility (0.00).Check USCTF's competition here
ACBD vs ATAQF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ATAQF has a market cap of 82.4M. Regarding current trading prices, ACBD is priced at $0.10, while ATAQF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ATAQF's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to ATAQF's ROE of +0.07%. Regarding short-term risk, ACBD is less volatile compared to ATAQF. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check ATAQF's competition here
ACBD vs GARLF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GARLF has a market cap of 81.8M. Regarding current trading prices, ACBD is priced at $0.10, while GARLF trades at $2.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GARLF's P/E ratio is -1.59. In terms of profitability, ACBD's ROE is +1.19%, compared to GARLF's ROE of -0.82%. Regarding short-term risk, ACBD is less volatile compared to GARLF. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check GARLF's competition here
ACBD vs WWHC Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, WWHC has a market cap of 80.2M. Regarding current trading prices, ACBD is priced at $0.10, while WWHC trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas WWHC's P/E ratio is -2.11. In terms of profitability, ACBD's ROE is +1.19%, compared to WWHC's ROE of +1.06%. Regarding short-term risk, ACBD and WWHC have similar daily volatility (0.00).Check WWHC's competition here
ACBD vs CNXX Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CNXX has a market cap of 77.6M. Regarding current trading prices, ACBD is priced at $0.10, while CNXX trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CNXX's P/E ratio is 34.17. In terms of profitability, ACBD's ROE is +1.19%, compared to CNXX's ROE of -0.07%. Regarding short-term risk, ACBD and CNXX have similar daily volatility (0.00).Check CNXX's competition here
ACBD vs CHAAW Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CHAAW has a market cap of 77.6M. Regarding current trading prices, ACBD is priced at $0.10, while CHAAW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CHAAW's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to CHAAW's ROE of -0.04%. Regarding short-term risk, ACBD and CHAAW have similar daily volatility (0.00).Check CHAAW's competition here
ACBD vs CREEF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CREEF has a market cap of 75M. Regarding current trading prices, ACBD is priced at $0.10, while CREEF trades at $10.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CREEF's P/E ratio is 36.47. In terms of profitability, ACBD's ROE is +1.19%, compared to CREEF's ROE of +0.16%. Regarding short-term risk, ACBD is less volatile compared to CREEF. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check CREEF's competition here
ACBD vs IDIG Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, IDIG has a market cap of 68.9M. Regarding current trading prices, ACBD is priced at $0.10, while IDIG trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas IDIG's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to IDIG's ROE of N/A. Regarding short-term risk, ACBD and IDIG have similar daily volatility (0.00).Check IDIG's competition here
ACBD vs CMCAF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CMCAF has a market cap of 67.9M. Regarding current trading prices, ACBD is priced at $0.10, while CMCAF trades at $11.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CMCAF's P/E ratio is 60.00. In terms of profitability, ACBD's ROE is +1.19%, compared to CMCAF's ROE of +5.07%. Regarding short-term risk, ACBD and CMCAF have similar daily volatility (0.00).Check CMCAF's competition here
ACBD vs GWIN Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GWIN has a market cap of 62.7M. Regarding current trading prices, ACBD is priced at $0.10, while GWIN trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GWIN's P/E ratio is -0.93. In terms of profitability, ACBD's ROE is +1.19%, compared to GWIN's ROE of +0.15%. Regarding short-term risk, ACBD and GWIN have similar daily volatility (0.00).Check GWIN's competition here
ACBD vs MDWK Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, MDWK has a market cap of 56.9M. Regarding current trading prices, ACBD is priced at $0.10, while MDWK trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas MDWK's P/E ratio is -12.50. In terms of profitability, ACBD's ROE is +1.19%, compared to MDWK's ROE of -3.08%. Regarding short-term risk, ACBD and MDWK have similar daily volatility (0.00).Check MDWK's competition here
ACBD vs PTCP Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, PTCP has a market cap of 56.7M. Regarding current trading prices, ACBD is priced at $0.10, while PTCP trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas PTCP's P/E ratio is -27.78. In terms of profitability, ACBD's ROE is +1.19%, compared to PTCP's ROE of N/A. Regarding short-term risk, ACBD and PTCP have similar daily volatility (0.00).Check PTCP's competition here
ACBD vs ATMS Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ATMS has a market cap of 55.8M. Regarding current trading prices, ACBD is priced at $0.10, while ATMS trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ATMS's P/E ratio is -8.30. In terms of profitability, ACBD's ROE is +1.19%, compared to ATMS's ROE of +1.78%. Regarding short-term risk, ACBD and ATMS have similar daily volatility (0.00).Check ATMS's competition here
ACBD vs AWCA Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, AWCA has a market cap of 51.9M. Regarding current trading prices, ACBD is priced at $0.10, while AWCA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas AWCA's P/E ratio is -13.49. In terms of profitability, ACBD's ROE is +1.19%, compared to AWCA's ROE of -0.41%. Regarding short-term risk, ACBD and AWCA have similar daily volatility (0.00).Check AWCA's competition here
ACBD vs GGAAF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GGAAF has a market cap of 50.7M. Regarding current trading prices, ACBD is priced at $0.10, while GGAAF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GGAAF's P/E ratio is -133.33. In terms of profitability, ACBD's ROE is +1.19%, compared to GGAAF's ROE of +0.00%. Regarding short-term risk, ACBD and GGAAF have similar daily volatility (0.00).Check GGAAF's competition here
ACBD vs AZRH Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, AZRH has a market cap of 48.9M. Regarding current trading prices, ACBD is priced at $0.10, while AZRH trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas AZRH's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to AZRH's ROE of -0.11%. Regarding short-term risk, ACBD is less volatile compared to AZRH. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check AZRH's competition here
ACBD vs JMTM Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, JMTM has a market cap of 48M. Regarding current trading prices, ACBD is priced at $0.10, while JMTM trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas JMTM's P/E ratio is -10.00. In terms of profitability, ACBD's ROE is +1.19%, compared to JMTM's ROE of +3.01%. Regarding short-term risk, ACBD is less volatile compared to JMTM. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check JMTM's competition here
ACBD vs KWAC Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, KWAC has a market cap of 46.2M. Regarding current trading prices, ACBD is priced at $0.10, while KWAC trades at $13.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas KWAC's P/E ratio is -23.75. In terms of profitability, ACBD's ROE is +1.19%, compared to KWAC's ROE of +0.03%. Regarding short-term risk, ACBD and KWAC have similar daily volatility (0.00).Check KWAC's competition here
ACBD vs KWACW Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, KWACW has a market cap of 46.2M. Regarding current trading prices, ACBD is priced at $0.10, while KWACW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas KWACW's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to KWACW's ROE of +0.03%. Regarding short-term risk, ACBD and KWACW have similar daily volatility (0.00).Check KWACW's competition here
ACBD vs AASP Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, AASP has a market cap of 46M. Regarding current trading prices, ACBD is priced at $0.10, while AASP trades at $4.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas AASP's P/E ratio is -16.21. In terms of profitability, ACBD's ROE is +1.19%, compared to AASP's ROE of -1.46%. Regarding short-term risk, ACBD and AASP have similar daily volatility (0.00).Check AASP's competition here
ACBD vs FSTJ Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, FSTJ has a market cap of 44.9M. Regarding current trading prices, ACBD is priced at $0.10, while FSTJ trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas FSTJ's P/E ratio is -51.00. In terms of profitability, ACBD's ROE is +1.19%, compared to FSTJ's ROE of -0.40%. Regarding short-term risk, ACBD and FSTJ have similar daily volatility (0.00).Check FSTJ's competition here
ACBD vs AOAO Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, AOAO has a market cap of 39M. Regarding current trading prices, ACBD is priced at $0.10, while AOAO trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas AOAO's P/E ratio is -3.64. In terms of profitability, ACBD's ROE is +1.19%, compared to AOAO's ROE of +16.98%. Regarding short-term risk, ACBD and AOAO have similar daily volatility (0.00).Check AOAO's competition here
ACBD vs ATMH Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ATMH has a market cap of 36.3M. Regarding current trading prices, ACBD is priced at $0.10, while ATMH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ATMH's P/E ratio is -6.69. In terms of profitability, ACBD's ROE is +1.19%, compared to ATMH's ROE of -0.29%. Regarding short-term risk, ACBD is less volatile compared to ATMH. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check ATMH's competition here
ACBD vs WBQNL Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, WBQNL has a market cap of 29.3M. Regarding current trading prices, ACBD is priced at $0.10, while WBQNL trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas WBQNL's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to WBQNL's ROE of +0.00%. Regarding short-term risk, ACBD is less volatile compared to WBQNL. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check WBQNL's competition here
ACBD vs RAFX Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, RAFX has a market cap of 27M. Regarding current trading prices, ACBD is priced at $0.10, while RAFX trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas RAFX's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to RAFX's ROE of -0.09%. Regarding short-term risk, ACBD is less volatile compared to RAFX. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check RAFX's competition here
ACBD vs EDGM Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, EDGM has a market cap of 26.9M. Regarding current trading prices, ACBD is priced at $0.10, while EDGM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas EDGM's P/E ratio is -0.55. In terms of profitability, ACBD's ROE is +1.19%, compared to EDGM's ROE of +1.99%. Regarding short-term risk, ACBD is less volatile compared to EDGM. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check EDGM's competition here
ACBD vs ADCV Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ADCV has a market cap of 26.7M. Regarding current trading prices, ACBD is priced at $0.10, while ADCV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ADCV's P/E ratio is -0.64. In terms of profitability, ACBD's ROE is +1.19%, compared to ADCV's ROE of N/A. Regarding short-term risk, ACBD and ADCV have similar daily volatility (0.00).Check ADCV's competition here
ACBD vs AVNI Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, AVNI has a market cap of 25.6M. Regarding current trading prices, ACBD is priced at $0.10, while AVNI trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas AVNI's P/E ratio is -20.10. In terms of profitability, ACBD's ROE is +1.19%, compared to AVNI's ROE of +1.17%. Regarding short-term risk, ACBD and AVNI have similar daily volatility (0.00).Check AVNI's competition here
ACBD vs LRGR Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, LRGR has a market cap of 24.6M. Regarding current trading prices, ACBD is priced at $0.10, while LRGR trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas LRGR's P/E ratio is -0.02. In terms of profitability, ACBD's ROE is +1.19%, compared to LRGR's ROE of +0.72%. Regarding short-term risk, ACBD is less volatile compared to LRGR. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check LRGR's competition here
ACBD vs ITRX Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ITRX has a market cap of 24.2M. Regarding current trading prices, ACBD is priced at $0.10, while ITRX trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ITRX's P/E ratio is -7.82. In terms of profitability, ACBD's ROE is +1.19%, compared to ITRX's ROE of N/A. Regarding short-term risk, ACBD and ITRX have similar daily volatility (0.00).Check ITRX's competition here
ACBD vs NPFC Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, NPFC has a market cap of 23.9M. Regarding current trading prices, ACBD is priced at $0.10, while NPFC trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas NPFC's P/E ratio is -17.86. In terms of profitability, ACBD's ROE is +1.19%, compared to NPFC's ROE of +1.75%. Regarding short-term risk, ACBD and NPFC have similar daily volatility (0.00).Check NPFC's competition here
ACBD vs CBBB Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CBBB has a market cap of 22.1M. Regarding current trading prices, ACBD is priced at $0.10, while CBBB trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CBBB's P/E ratio is -0.87. In terms of profitability, ACBD's ROE is +1.19%, compared to CBBB's ROE of +0.00%. Regarding short-term risk, ACBD is less volatile compared to CBBB. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check CBBB's competition here
ACBD vs GIPL Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GIPL has a market cap of 20.2M. Regarding current trading prices, ACBD is priced at $0.10, while GIPL trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GIPL's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to GIPL's ROE of -3.74%. Regarding short-term risk, ACBD and GIPL have similar daily volatility (0.00).Check GIPL's competition here
ACBD vs CAHO Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CAHO has a market cap of 19.1M. Regarding current trading prices, ACBD is priced at $0.10, while CAHO trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CAHO's P/E ratio is -51.40. In terms of profitability, ACBD's ROE is +1.19%, compared to CAHO's ROE of +0.40%. Regarding short-term risk, ACBD and CAHO have similar daily volatility (0.00).Check CAHO's competition here
ACBD vs ADIA Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ADIA has a market cap of 16.4M. Regarding current trading prices, ACBD is priced at $0.10, while ADIA trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ADIA's P/E ratio is -0.43. In terms of profitability, ACBD's ROE is +1.19%, compared to ADIA's ROE of +1.00%. Regarding short-term risk, ACBD and ADIA have similar daily volatility (0.00).Check ADIA's competition here
ACBD vs STLY Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, STLY has a market cap of 15.3M. Regarding current trading prices, ACBD is priced at $0.10, while STLY trades at $5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas STLY's P/E ratio is 11.91. In terms of profitability, ACBD's ROE is +1.19%, compared to STLY's ROE of +0.05%. Regarding short-term risk, ACBD and STLY have similar daily volatility (0.00).Check STLY's competition here
ACBD vs GTVI Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GTVI has a market cap of 15.3M. Regarding current trading prices, ACBD is priced at $0.10, while GTVI trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GTVI's P/E ratio is -3.65. In terms of profitability, ACBD's ROE is +1.19%, compared to GTVI's ROE of +0.83%. Regarding short-term risk, ACBD and GTVI have similar daily volatility (0.00).Check GTVI's competition here
ACBD vs BOREF Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, BOREF has a market cap of 14.9M. Regarding current trading prices, ACBD is priced at $0.10, while BOREF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas BOREF's P/E ratio is -33.33. In terms of profitability, ACBD's ROE is +1.19%, compared to BOREF's ROE of +0.06%. Regarding short-term risk, ACBD and BOREF have similar daily volatility (0.00).Check BOREF's competition here
ACBD vs WRPT Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, WRPT has a market cap of 14.7M. Regarding current trading prices, ACBD is priced at $0.10, while WRPT trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas WRPT's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to WRPT's ROE of -0.15%. Regarding short-term risk, ACBD and WRPT have similar daily volatility (0.00).Check WRPT's competition here
ACBD vs BTOW Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, BTOW has a market cap of 14.5M. Regarding current trading prices, ACBD is priced at $0.10, while BTOW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas BTOW's P/E ratio is -0.10. In terms of profitability, ACBD's ROE is +1.19%, compared to BTOW's ROE of +0.00%. Regarding short-term risk, ACBD and BTOW have similar daily volatility (0.00).Check BTOW's competition here
ACBD vs XCPT Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, XCPT has a market cap of 13.7M. Regarding current trading prices, ACBD is priced at $0.10, while XCPT trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas XCPT's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to XCPT's ROE of N/A. Regarding short-term risk, ACBD is less volatile compared to XCPT. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check XCPT's competition here
ACBD vs ECGR Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ECGR has a market cap of 13.4M. Regarding current trading prices, ACBD is priced at $0.10, while ECGR trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ECGR's P/E ratio is -20.00. In terms of profitability, ACBD's ROE is +1.19%, compared to ECGR's ROE of -1.14%. Regarding short-term risk, ACBD is less volatile compared to ECGR. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check ECGR's competition here
ACBD vs USBL Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, USBL has a market cap of 13.1M. Regarding current trading prices, ACBD is priced at $0.10, while USBL trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas USBL's P/E ratio is -0.81. In terms of profitability, ACBD's ROE is +1.19%, compared to USBL's ROE of +0.14%. Regarding short-term risk, ACBD is less volatile compared to USBL. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check USBL's competition here
ACBD vs LNMG Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, LNMG has a market cap of 13.1M. Regarding current trading prices, ACBD is priced at $0.10, while LNMG trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas LNMG's P/E ratio is 2.57. In terms of profitability, ACBD's ROE is +1.19%, compared to LNMG's ROE of +0.07%. Regarding short-term risk, ACBD and LNMG have similar daily volatility (0.00).Check LNMG's competition here
ACBD vs SIPN Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, SIPN has a market cap of 10.4M. Regarding current trading prices, ACBD is priced at $0.10, while SIPN trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas SIPN's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to SIPN's ROE of +0.01%. Regarding short-term risk, ACBD and SIPN have similar daily volatility (0.00).Check SIPN's competition here
ACBD vs ADHI Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ADHI has a market cap of 9.4M. Regarding current trading prices, ACBD is priced at $0.10, while ADHI trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ADHI's P/E ratio is -0.04. In terms of profitability, ACBD's ROE is +1.19%, compared to ADHI's ROE of -0.06%. Regarding short-term risk, ACBD is less volatile compared to ADHI. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check ADHI's competition here
ACBD vs FWFW Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, FWFW has a market cap of 8.8M. Regarding current trading prices, ACBD is priced at $0.10, while FWFW trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas FWFW's P/E ratio is -1.57. In terms of profitability, ACBD's ROE is +1.19%, compared to FWFW's ROE of -2.72%. Regarding short-term risk, ACBD and FWFW have similar daily volatility (0.00).Check FWFW's competition here
ACBD vs EVTK Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, EVTK has a market cap of 8.4M. Regarding current trading prices, ACBD is priced at $0.10, while EVTK trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas EVTK's P/E ratio is -200.00. In terms of profitability, ACBD's ROE is +1.19%, compared to EVTK's ROE of +0.74%. Regarding short-term risk, ACBD and EVTK have similar daily volatility (0.00).Check EVTK's competition here
ACBD vs PSCO Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, PSCO has a market cap of 8.3M. Regarding current trading prices, ACBD is priced at $0.10, while PSCO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas PSCO's P/E ratio is -0.40. In terms of profitability, ACBD's ROE is +1.19%, compared to PSCO's ROE of +0.00%. Regarding short-term risk, ACBD and PSCO have similar daily volatility (0.00).Check PSCO's competition here
ACBD vs LWLW Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, LWLW has a market cap of 8.1M. Regarding current trading prices, ACBD is priced at $0.10, while LWLW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas LWLW's P/E ratio is -10.00. In terms of profitability, ACBD's ROE is +1.19%, compared to LWLW's ROE of -19.61%. Regarding short-term risk, ACBD and LWLW have similar daily volatility (0.00).Check LWLW's competition here
ACBD vs ARVY Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ARVY has a market cap of 7.7M. Regarding current trading prices, ACBD is priced at $0.10, while ARVY trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ARVY's P/E ratio is -0.52. In terms of profitability, ACBD's ROE is +1.19%, compared to ARVY's ROE of +0.21%. Regarding short-term risk, ACBD and ARVY have similar daily volatility (0.00).Check ARVY's competition here
ACBD vs SDAD Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, SDAD has a market cap of 7.7M. Regarding current trading prices, ACBD is priced at $0.10, while SDAD trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas SDAD's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to SDAD's ROE of N/A. Regarding short-term risk, ACBD and SDAD have similar daily volatility (0.00).Check SDAD's competition here
ACBD vs ELLH Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ELLH has a market cap of 7.7M. Regarding current trading prices, ACBD is priced at $0.10, while ELLH trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ELLH's P/E ratio is -3.20. In terms of profitability, ACBD's ROE is +1.19%, compared to ELLH's ROE of -0.39%. Regarding short-term risk, ACBD and ELLH have similar daily volatility (0.00).Check ELLH's competition here
ACBD vs HGYN Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, HGYN has a market cap of 7.4M. Regarding current trading prices, ACBD is priced at $0.10, while HGYN trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas HGYN's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to HGYN's ROE of -0.28%. Regarding short-term risk, ACBD is less volatile compared to HGYN. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check HGYN's competition here
ACBD vs ILXP Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ILXP has a market cap of 7.2M. Regarding current trading prices, ACBD is priced at $0.10, while ILXP trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ILXP's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to ILXP's ROE of +0.00%. Regarding short-term risk, ACBD and ILXP have similar daily volatility (0.00).Check ILXP's competition here
ACBD vs PCMC Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, PCMC has a market cap of 7.2M. Regarding current trading prices, ACBD is priced at $0.10, while PCMC trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas PCMC's P/E ratio is -1.04. In terms of profitability, ACBD's ROE is +1.19%, compared to PCMC's ROE of +0.22%. Regarding short-term risk, ACBD and PCMC have similar daily volatility (0.00).Check PCMC's competition here
ACBD vs TCRI Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, TCRI has a market cap of 6.8M. Regarding current trading prices, ACBD is priced at $0.10, while TCRI trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas TCRI's P/E ratio is -10.50. In terms of profitability, ACBD's ROE is +1.19%, compared to TCRI's ROE of +0.16%. Regarding short-term risk, ACBD and TCRI have similar daily volatility (0.00).Check TCRI's competition here
ACBD vs NXMH Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, NXMH has a market cap of 6.3M. Regarding current trading prices, ACBD is priced at $0.10, while NXMH trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas NXMH's P/E ratio is -1.44. In terms of profitability, ACBD's ROE is +1.19%, compared to NXMH's ROE of +2.88%. Regarding short-term risk, ACBD and NXMH have similar daily volatility (0.00).Check NXMH's competition here
ACBD vs CHYL Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CHYL has a market cap of 5.7M. Regarding current trading prices, ACBD is priced at $0.10, while CHYL trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CHYL's P/E ratio is 10.00. In terms of profitability, ACBD's ROE is +1.19%, compared to CHYL's ROE of +0.23%. Regarding short-term risk, ACBD and CHYL have similar daily volatility (0.00).Check CHYL's competition here
ACBD vs WHLT Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, WHLT has a market cap of 5.5M. Regarding current trading prices, ACBD is priced at $0.10, while WHLT trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas WHLT's P/E ratio is -8.90. In terms of profitability, ACBD's ROE is +1.19%, compared to WHLT's ROE of -0.28%. Regarding short-term risk, ACBD and WHLT have similar daily volatility (0.00).Check WHLT's competition here
ACBD vs GPLL Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GPLL has a market cap of 5.4M. Regarding current trading prices, ACBD is priced at $0.10, while GPLL trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GPLL's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to GPLL's ROE of +0.12%. Regarding short-term risk, ACBD and GPLL have similar daily volatility (0.00).Check GPLL's competition here
ACBD vs NFTM Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, NFTM has a market cap of 5.3M. Regarding current trading prices, ACBD is priced at $0.10, while NFTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas NFTM's P/E ratio is -0.12. In terms of profitability, ACBD's ROE is +1.19%, compared to NFTM's ROE of +0.01%. Regarding short-term risk, ACBD and NFTM have similar daily volatility (0.00).Check NFTM's competition here
ACBD vs NRCD Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, NRCD has a market cap of 5.2M. Regarding current trading prices, ACBD is priced at $0.10, while NRCD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas NRCD's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to NRCD's ROE of N/A. Regarding short-term risk, ACBD and NRCD have similar daily volatility (0.00).Check NRCD's competition here
ACBD vs NGRC Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, NGRC has a market cap of 5.1M. Regarding current trading prices, ACBD is priced at $0.10, while NGRC trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas NGRC's P/E ratio is -1.65. In terms of profitability, ACBD's ROE is +1.19%, compared to NGRC's ROE of +0.05%. Regarding short-term risk, ACBD and NGRC have similar daily volatility (0.00).Check NGRC's competition here
ACBD vs ASNB Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ASNB has a market cap of 4.8M. Regarding current trading prices, ACBD is priced at $0.10, while ASNB trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ASNB's P/E ratio is -0.60. In terms of profitability, ACBD's ROE is +1.19%, compared to ASNB's ROE of -0.07%. Regarding short-term risk, ACBD is less volatile compared to ASNB. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check ASNB's competition here
ACBD vs XITO Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, XITO has a market cap of 4.8M. Regarding current trading prices, ACBD is priced at $0.10, while XITO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas XITO's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to XITO's ROE of +0.28%. Regarding short-term risk, ACBD is less volatile compared to XITO. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check XITO's competition here
ACBD vs MTRI Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, MTRI has a market cap of 4.6M. Regarding current trading prices, ACBD is priced at $0.10, while MTRI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas MTRI's P/E ratio is 12.50. In terms of profitability, ACBD's ROE is +1.19%, compared to MTRI's ROE of N/A. Regarding short-term risk, ACBD is less volatile compared to MTRI. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check MTRI's competition here
ACBD vs CDBT Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CDBT has a market cap of 4.1M. Regarding current trading prices, ACBD is priced at $0.10, while CDBT trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CDBT's P/E ratio is -5.00. In terms of profitability, ACBD's ROE is +1.19%, compared to CDBT's ROE of +0.15%. Regarding short-term risk, ACBD is less volatile compared to CDBT. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check CDBT's competition here
ACBD vs SMEV Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, SMEV has a market cap of 4M. Regarding current trading prices, ACBD is priced at $0.10, while SMEV trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas SMEV's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to SMEV's ROE of +0.19%. Regarding short-term risk, ACBD and SMEV have similar daily volatility (0.00).Check SMEV's competition here
ACBD vs CAVG Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, CAVG has a market cap of 3.8M. Regarding current trading prices, ACBD is priced at $0.10, while CAVG trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas CAVG's P/E ratio is -3.75. In terms of profitability, ACBD's ROE is +1.19%, compared to CAVG's ROE of +1.22%. Regarding short-term risk, ACBD and CAVG have similar daily volatility (0.00).Check CAVG's competition here
ACBD vs SITS Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, SITS has a market cap of 3.8M. Regarding current trading prices, ACBD is priced at $0.10, while SITS trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas SITS's P/E ratio is -0.65. In terms of profitability, ACBD's ROE is +1.19%, compared to SITS's ROE of -1.13%. Regarding short-term risk, ACBD and SITS have similar daily volatility (0.00).Check SITS's competition here
ACBD vs ENGA Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, ENGA has a market cap of 3.7M. Regarding current trading prices, ACBD is priced at $0.10, while ENGA trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas ENGA's P/E ratio is -16.00. In terms of profitability, ACBD's ROE is +1.19%, compared to ENGA's ROE of N/A. Regarding short-term risk, ACBD and ENGA have similar daily volatility (0.00).Check ENGA's competition here
ACBD vs MVCO Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, MVCO has a market cap of 3.6M. Regarding current trading prices, ACBD is priced at $0.10, while MVCO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas MVCO's P/E ratio is -0.09. In terms of profitability, ACBD's ROE is +1.19%, compared to MVCO's ROE of +5.95%. Regarding short-term risk, ACBD is less volatile compared to MVCO. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check MVCO's competition here
ACBD vs INOQ Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, INOQ has a market cap of 3.6M. Regarding current trading prices, ACBD is priced at $0.10, while INOQ trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas INOQ's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to INOQ's ROE of +0.94%. Regarding short-term risk, ACBD and INOQ have similar daily volatility (0.00).Check INOQ's competition here
ACBD vs HPIL Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, HPIL has a market cap of 3.6M. Regarding current trading prices, ACBD is priced at $0.10, while HPIL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas HPIL's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to HPIL's ROE of +2.62%. Regarding short-term risk, ACBD and HPIL have similar daily volatility (0.00).Check HPIL's competition here
ACBD vs IWSH Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, IWSH has a market cap of 3.5M. Regarding current trading prices, ACBD is priced at $0.10, while IWSH trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas IWSH's P/E ratio is -3.40. In terms of profitability, ACBD's ROE is +1.19%, compared to IWSH's ROE of -0.51%. Regarding short-term risk, ACBD is less volatile compared to IWSH. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check IWSH's competition here
ACBD vs GEGP Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, GEGP has a market cap of 3.4M. Regarding current trading prices, ACBD is priced at $0.10, while GEGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas GEGP's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to GEGP's ROE of +0.33%. Regarding short-term risk, ACBD is less volatile compared to GEGP. This indicates potentially lower risk in terms of short-term price fluctuations for ACBD.Check GEGP's competition here
ACBD vs BDCM Comparison February 2026
ACBD plays a significant role within the Financial Services sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ACBD stands at 4.1M. In comparison, BDCM has a market cap of 3.1M. Regarding current trading prices, ACBD is priced at $0.10, while BDCM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ACBD currently has a P/E ratio of N/A, whereas BDCM's P/E ratio is N/A. In terms of profitability, ACBD's ROE is +1.19%, compared to BDCM's ROE of +88.57%. Regarding short-term risk, ACBD and BDCM have similar daily volatility (0.00).Check BDCM's competition here